Cargando…
The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection
Erythropoietin (EPO) is traditionally described as a hematopoietic cytokine or growth hormone regulating proliferation, differentiation, and survival of erythroid progenitors. The use of EPO in patients with chronic kidney disease (CKD) was a milestone achievement in the treatment of anemia. However...
Autores principales: | Bartnicki, Piotr, Kowalczyk, Mariusz, Rysz, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724571/ https://www.ncbi.nlm.nih.gov/pubmed/23872600 http://dx.doi.org/10.12659/MSM.889023 |
Ejemplares similares
-
Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011) -
New Insights into the Nephroprotective Potential of Lercanidipine
por: Hajdys, Joanna, et al.
Publicado: (2023) -
Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease
por: Bartnicki, Piotr, et al.
Publicado: (2016) -
Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer
por: Jagieła, Joanna, et al.
Publicado: (2021) -
The pleiotropic effects of erythropoietin in infection and inflammation
por: Nairz, Manfred, et al.
Publicado: (2012)